Page last updated: 2024-08-17

methionine and Chondrodystrophic Myotonia

methionine has been researched along with Chondrodystrophic Myotonia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dawson, PA	1
Boot-Handford, RP; Briggs, MD; Heinegård, D; Kadler, KE; Knowles, L; Meadows, RS; Piróg-Garcia, KA; Thornton, DJ	1
Bamshad, MJ; Bellus, GA; Curry, CJ; Dorst, J; Francomano, CA; Hurko, O; Jabs, EW; Lachman, RS; Lee, RR; Przylepa, KA; Rimoin, DL; Wilcox, WR	1

Reviews

1 review(s) available for methionine and Chondrodystrophic Myotonia

Article	Year
Sulfate in fetal development. Seminars in cell & developmental biology, 2011, Volume: 22, Issue:6 Topics: Adult; Cartilage; Child; Cysteine; Developmental Biology; Embryo, Mammalian; Female; Fetal Development; Fetus; Humans; Infant, Newborn; Infant, Newborn, Diseases; Membrane Transport Proteins; Methionine; Osteochondrodysplasias; Phosphoadenosine Phosphosulfate; Pregnancy; Proteoglycans; Sulfatases; Sulfate Transporters; Sulfates; Sulfotransferases	2011

Article

Year

Sulfate in fetal development.

Seminars in cell & developmental biology, 2011, Volume: 22, Issue:6

Topics: Adult; Cartilage; Child; Cysteine; Developmental Biology; Embryo, Mammalian; Female; Fetal Development; Fetus; Humans; Infant, Newborn; Infant, Newborn, Diseases; Membrane Transport Proteins; Methionine; Osteochondrodysplasias; Phosphoadenosine Phosphosulfate; Pregnancy; Proteoglycans; Sulfatases; Sulfate Transporters; Sulfates; Sulfotransferases

2011

Other Studies

2 other study(ies) available for methionine and Chondrodystrophic Myotonia

Article	Year
Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP. Human molecular genetics, 2007, Sep-01, Volume: 16, Issue:17 Topics: Achondroplasia; Animals; Apoptosis; Cell Proliferation; Chondrocytes; Disease Models, Animal; Dwarfism; Endoplasmic Reticulum; Extracellular Matrix Proteins; Female; Glycoproteins; Male; Matrilin Proteins; Methionine; Mice; Mice, Knockout; Mutation; Osteochondrodysplasias; Phenotype; Protein Structure, Tertiary; Threonine	2007
Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3. American journal of medical genetics, 1999, Jul-02, Volume: 85, Issue:1 Topics: Acanthosis Nigricans; Developmental Disabilities; Female; Humans; Infant, Newborn; Lysine; Male; Methionine; Osteochondrodysplasias; Phenotype; Point Mutation; Protein-Tyrosine Kinases; Radiography; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Fibroblast Growth Factor; Skull	1999

Article

Year

Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP.

Human molecular genetics, 2007, Sep-01, Volume: 16, Issue:17

Topics: Achondroplasia; Animals; Apoptosis; Cell Proliferation; Chondrocytes; Disease Models, Animal; Dwarfism; Endoplasmic Reticulum; Extracellular Matrix Proteins; Female; Glycoproteins; Male; Matrilin Proteins; Methionine; Mice; Mice, Knockout; Mutation; Osteochondrodysplasias; Phenotype; Protein Structure, Tertiary; Threonine

2007

Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3.

American journal of medical genetics, 1999, Jul-02, Volume: 85, Issue:1

Topics: Acanthosis Nigricans; Developmental Disabilities; Female; Humans; Infant, Newborn; Lysine; Male; Methionine; Osteochondrodysplasias; Phenotype; Point Mutation; Protein-Tyrosine Kinases; Radiography; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Fibroblast Growth Factor; Skull

1999